French medical-imaging market worth 800 million euros

4 September 2011

Medical imaging is an extremely open and dynamic sector in France, thanks to government initiatives which have attracted inward investment: the French in vivo medical-imaging market is estimated to be worth about 800 million euros ($1.15 billion), in a global market that was valued at 20 billion euros in 2010, reports Invest in France Agency (IFA), France's national agency responsible for promoting and facilitating international investment in France.

Ground-breaking partnerships are being set up between France's clusters of excellence and international businesses: more than 650 non-French companies belong to one of France's 71 innovation clusters, in areas that include medical imaging and related fields, IFA notes.

The market for medical imaging comprises three different segments: traditional imaging techniques (radiography and ultrasound), which account for 59% of the market; endoscopy, which accounts for 19%; and, finally, the large instrument segment (CT, MRI and PET scanners), which makes up the remaining 22%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical